Skip to main content
Figure 1 | BMC Gastroenterology

Figure 1

From: Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination

Figure 1

On-treatment virological and biochemical response. LLQ1: Lower limit of quantification (Amplicor HBV-Monitor; Roche Diagnostic Systems, Branchburg, NJ); LLQ2: Lower limit of quantification (COBAS TaqMan 48; Roche, Branchburg, NJ); IFN: interferon; ETV: entecavir; ADV: adefovir dipivoxil; TDV: tenofovir. HBsAb quantification (protective value > 100 mIU/ml): Roche Modular Analytics E601 assay.

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us